Aktuelle Nachrichten zu Heartbeam
-0,33% BioTelemetry Inc. - US-Dollar Indikation -
Auch BioTelemetry steht kurz davor die Trendfortsetzung einzuleiten. Mit einer Marktkapitalisierung von 2,44 Mrd. USD und einem Trendstabilitätswert von 12,44 belegt das Unternehmen den 10. Platz unserer...- ‹
- 1
- ›
Aktuelle Nachrichten anderer Redaktionen zu Heartbeam
Beyond Air (XAIR) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATETuesday, June 17, 2025, at 4:30 p.m. EDTCALL PARTICIPANTSChairman and Chief Executive Officer — Steven Adam LisiChief Financial Officer — Douglas Quinton LarsonNeed a quote from one of our analysts? Email [email protected] Profit Loss: Chief Financial Officer Larson reported, We reported a $1.7 million gross profit loss for FY2025, compared to $1.3 million in FY2024, primarily due to device depreciation and upgrade costs.Operating Cash Position: Larson ...
Global Clinical Trial Imaging Market Size To Exceed USD 4.46 Billion By 2033 l CAGR of 8.57%
The Global Clinical Trial Imaging Market Size was Valued at USD 1.96 Billion in 2023, the Worldwide Clinical Trial Imaging Market Size is Expected to Reach USD 4.46 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Intrinsic Imaging, BioTelemetry, ProScan Imaging, Medpace, Biomedical Systems Corp, IXICO plc, Resonance Health, Navitas Life Sciences, Cardiovascular Imaging Technologies, Radiant Sage LLC, WCG Clinical, Medidata, WorldCa...
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.